TEMPORARY REMOVAL: Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: Primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial
| العنوان: | TEMPORARY REMOVAL: Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: Primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial |
|---|---|
| المؤلفون: | N. Harbeck, P.A. Fasching, R. Würstlein, T. Degenhardt, D. Lüftner, R.E. Kates, J. Schumacher, P. Räth, O. Hoffmann, R. Lorenz, T. Decker, M. Reinisch, T. Göhler, P. Staib, O. Gluz, T. Schinköthe, M. Schmidt |
| المصدر: | Annals of Oncology. |
| بيانات النشر: | Elsevier BV, 2023. |
| سنة النشر: | 2023 |
| مصطلحات موضوعية: | Oncology, Hematology |
| تدمد: | 0923-7534 |
| DOI: | 10.1016/j.annonc.2023.05.003 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::e347079a7593ff0fafbe298fe67889a3 https://doi.org/10.1016/j.annonc.2023.05.003 |
| Rights: | OPEN |
| رقم الانضمام: | edsair.doi...........e347079a7593ff0fafbe298fe67889a3 |
| قاعدة البيانات: | OpenAIRE |
كن أول من يترك تعليقا!